XWELL
Operates airport spas, public-health biosurveillance collection and off-airport waxing retail.
Something off on this page? Send us feedback.
Profile
Operates airport spas, airport-based public-health biosurveillance collection and off-airport waxing and wellness retail. A pending sale would transfer the airport-spa and biosurveillance businesses, leaving the off-airport retail operations while the parent pursues an unspecified national-security direction.
Operates airport wellness locations under XpresSpa, selling massages, nail and skin-care services, spa products and travel products. Its airport network includes domestic terminals and international locations in the Netherlands, Turkey and the United Arab Emirates, while Naples Wax Center provides face and body waxing, skin-care services and cosmetics through Florida locations.
Collects passenger nasal samples and aircraft wastewater for the CDC-linked Traveler-based Genomic Surveillance program through XpresTest; its diagnostic-testing centers are closed. The company has agreed to sell the airport-spa and biosurveillance businesses, retain off-airport wellness retail and pursue an unspecified national-security direction.
Until the sale closes, airport operations depend on passenger traffic, concession agreements and licensed personnel, while biosurveillance revenue relies on CDC-funded work performed in collaboration with Ginkgo Bioworks. The transaction requires stockholder approval and other closing conditions.
Company facts
Key statistics
Year to date +128% · Average volume (30d) 34.4K
Analysts
No analyst consensus on record.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026Q2 FY26 | −$1.00 | −$0.26 | +74.0% | $2.4M | $7.1M | +201.4% | −2.97% |
| May 20, 2026Q1 FY26 | −$1.00 | −$1.51 | −51.0% | $2.4M | $6.6M | +180.0% | −0.68% |
| Apr 1, 2026Q4 FY25 | −$1.00 | −$3.26 | −226.0% | $2.4M | $7.2M | +201.7% | −7.76% |
| Nov 14, 2025Q3 FY25 | — | −$0.26 | — | — | $7.3M | — | +11.79% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $7.0M | $7.7M | $7.3M | $7.2M | $6.6M | $7.1M | |
| Gross profit | $1.3M | $1.8M | $1.3M | $2.3M | $2.2M | $2.9M | |
| Operating income | −$3.2M | −$2.7M | −$282.0K | −$3.2M | −$5.4M | $2.1M | |
| Net income | −$4.7M | −$2.3M | −$724.0K | −$9.3M | −$11.2M | −$2.2M | |
| Diluted EPS | −$1.00 | −$0.56 | −$0.26 | −$3.26 | −$1.51 | −$0.26 | |
| Gross margin | 18.8% | 23.1% | 17.3% | 31.8% | 32.9% | 41.3% | |
| Operating margin | -45.0% | -35.0% | -3.8% | -45.1% | -81.6% | 29.3% |
Fiscal years (4-quarter sums)FY21 $73.7M · FY22 $55.9M · FY23 $30.1M · FY24 $33.9M · FY25 $29.2M
Revenue by product · Q2 FY26
Revenue by geography · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $11.8M · Total debt $7.3M · Total assets $20.5M · Shareholders' equity −$1.9M
Dividends
No dividends on record.
Ownership
Shares outstanding 7.93M · Float 6.45M · 81.3% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Bruce Bernstein | 602.6K | 6.90% | 13D | Aug 4, 2026 |
| McCabe James Joseph III | 319.0K | 5.50% | 13G | Mar 11, 2026 |
| Robert Weinstein · director | 215.2K | 2.72% | Form 4 | Mar 2, 2026 |
| Michael Lebowitz · director | 211.1K | 2.66% | Form 4 | Mar 2, 2026 |
| Ezra Ernst · officer: President and CEO | 201.1K | 2.54% | Form 4 | Mar 2, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
View detailsPeers
- OneSpaWorld
Travel wellness overlap in massage, skin care, and product sales.
- Ulta Beauty
Salon, skin-care, and cosmetics rival local waxing-center spend.
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| XWELL | $1.00 | −2.44% | $8.0M | — | — | 0.3 | −7.1% |
| OneSpaWorld | $25.26 | 0.00% | $2.56B | 32.0 | 20.9 | 2.5 | +8.5% |
| Ulta Beauty | $517.11 | −0.08% | $22.25B | 18.8 | 17.1 | 1.7 | +8.9% |
| Median | 25.4 | 19.0 | 2.1 | +8.7% |